- Record: found
- Abstract: found
- Article: not found
Nomogram Based on Monocyte-to-Lymphocyte Ratio to Predict Survival of Unresectable Esophageal Squamous Cell Carcinoma Who Receive First-Line PD-1/PD-L1 Inhibitors Combined with Chemotherapy.
Xiaolu Ma
1 ,
Yongfeng Ding
1 ,
Jiong Qian
1 ,
Mingyu Wan
1 ,
Ning Li
1 ,
Chenyu Mao
1 ,
Cheng Xiao
1 ,
Haiping Jiang
1 ,
Yulong Zheng
1 ,
Luntao Wu
1 ,
Xiaoyu Chen
1 ,
Nong Xu
1
Nov 18 2022
Read this article at
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
Chemoimmunotherapy has become the first-line treatment for unresectable esophageal squamous cell carcinoma (ESCC). Still, reliable biomarkers to identify patients who could benefit from this combined therapy remain uncertain. This study focused on elucidating the predictive significance of the monocyte-to-lymphocyte ratio (MLR) and establishing the prognostic nomogram for unresectable ESCC treated with chemoimmunotherapy.